Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Division of Biostatics, Center for Medical Research and Information, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Am J Cardiol. 2020 Apr 15;125(8):1148-1153. doi: 10.1016/j.amjcard.2020.01.023. Epub 2020 Jan 29.
Patients who underwent myocardial revascularization for significant left main coronary artery disease (LMCA) are at high risks of ischemic events and death during follow-up. We sought to determine the independent correlates for very long-term outcomes after LMCA revascularization, which would be clinical value for risk stratification in such high-risk patients. The 10-year rates of clinical outcomes and independent correlates of adverse events were evaluated in 2,240 patients with LMCA disease in the MAIN-COMPARE registry, including 1,102 patients who underwent stenting and 1,138 who underwent coronary artery bypass grafting. The primary outcome was the composite of all-cause death, Q-wave myocardial infarction, or stroke. Secondary outcomes were all-cause mortality and target-vessel revascularization (TVR). The 10-year rates of the primary composite outcome, all-cause mortality, and TVR were 24.7%, 22.2%, and 13.6%, respectively. Age >65 years, diabetes, previous heart failure, cerebrovascular disease, peripheral arterial disease, chronic renal failure, atrial fibrillation, ejection fraction <40%, and distal LMCA bifurcation disease were independent correlates of the primary outcome in the overall population. Several clinical and anatomic parameters were also identified as independent correlates of all-cause death and TVR. Interaction analysis showed no heterogeneities of the effects of variables depending on revascularization type. These clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for patients who underwent LMCA revascularization.
对于存在严重左主干冠状动脉疾病(LMCA)的患者,经心肌血运重建后在随访期间发生缺血事件和死亡的风险较高。我们旨在确定 LMCA 血运重建后非常长期结局的独立相关因素,这对于此类高危患者的风险分层具有临床价值。在 MAIN-COMPARE 注册研究中,评估了 2240 例 LMCA 疾病患者的 10 年临床结局和不良事件的独立相关因素,包括 1102 例行支架置入术和 1138 例行冠状动脉旁路移植术的患者。主要结局是全因死亡、Q 波心肌梗死或卒中的复合终点。次要结局是全因死亡率和靶血管血运重建(TVR)。主要复合结局、全因死亡率和 TVR 的 10 年发生率分别为 24.7%、22.2%和 13.6%。年龄>65 岁、糖尿病、既往心力衰竭、脑血管疾病、外周动脉疾病、慢性肾衰竭、心房颤动、射血分数<40%和 LMCA 远端分叉病变是全人群中主要结局的独立相关因素。一些临床和解剖参数也被确定为全因死亡和 TVR 的独立相关因素。交互分析显示,取决于血运重建类型的变量的影响没有异质性。这些临床特征可帮助临床医生识别接受 LMCA 血运重建的患者中广泛风险范围内的高危患者。